Jeffrey Beekman is a Full Professor at the University Medical Center Utrecht, specializing in translational research for chronic diseases through the Department of Pediatric Pulmonology. His work bridges basic and clinical research to develop novel diagnostics and therapeutics for conditions like cystic fibrosis (CF) and Primary Ciliary Dyskinesia. Education: PhD in Molecular Immunology (2004) Key Roles: Principle Investigator since 2010, co-founder of FAIR Therapeutics, Board Member of the Dutch Society for Stem Cell Research His research focuses on patient-derived organoid models to study disease mechanisms, validate therapeutic targets, and optimize drug development. Strategic programs include Child Health and Regenerative Medicine & Stem Cells . Recent publications highlight his work on CFTR gene therapy, organoid-based drug efficacy testing, and host-pathogen interactions in CF. Collaborations span molecular biology, clinical pulmonology, and biotech translation. Key Techniques: Organoid modeling, RNA sequencing, Forskolin-induced swelling assay Diseases Studied: Cystic Fibrosis, Colorectal Cancer Susceptibility, Primary Ciliary Dyskinesia
Prof. Carlijn V.C. Bouten is Full Professor of Cell-Matrix Interactions in Cardiovascular Regeneration at Eindhoven University of Technology (TU/e), where she heads the Soft Tissue Engineering & Mechanobiology research group in the Department of Biomedical Engineering. She leads a team of ~40 researchers focusing on cardiovascular tissue regeneration through interdisciplinary approaches. Her research investigates mechanobiological interactions between cells and extracellular environments during tissue growth/regeneration, using multi-scale living model systems. Key innovations include biodegradable heart valve prostheses, hybrid implantable organs, and remote cardiac tissue engineering concepts. She collaborates with material scientists, clinicians, and medtech companies. Education includes an MSc in Functional Anatomy and Biomechanics (Vrije Universiteit Amsterdam, 1991) and PhD (TU/e, 1995), with postdoctoral training at Université Laval and University of London. Her 300+ publications focus on: Cardiovascular tissue engineering Cell-matrix mechanobiology In vitro tissue models Biodegradable implants Hybrid organ development Major scientific honors: ERC Advanced Grant (2022) VICI Grant (2003) Aspasia Career Development Award Coordinator of €18.8M Gravitation Programme Elected member of KNAW and AcademiaNet She leads multiple consortia including RegMed-XB's Cardiac Moonshot and international programs like FET-OPEN 'Hybrid Heart'. Heads TU/e's Soft Tissue Engineering & Mechanobiology lab developing advanced biomaterials and tissue models.
Carlijn Bouten is Full Professor of Cell-Matrix Interactions in Cardiovascular Regeneration at Eindhoven University of Technology. She leads the Soft Tissue Engineering & Mechanobiology group, investigating cellular interactions with extracellular environments in tissue growth, adaptation, and regeneration. Her research develops biodegradable heart valve prostheses that enable in vivo tissue regeneration, applying tissue engineering approaches to cardiovascular medicine. Professor Bouten holds an MSc from Vrije Universiteit Amsterdam and a PhD from TU/e. She completed postdoctoral research at Université Laval and University of London before joining TU/e's faculty. She directs the national Gravitation program 'Materials-Driven Regeneration' and received an ERC Advanced Grant for cardiac tissue organization research. Research Focus: Her interdisciplinary program spans: Mechanobiological cues in tissue regeneration Development of living heart valve replacements Advanced biomaterials for cardiovascular applications In vitro models for tissue development Soft robotic systems for cardiac assistance Recent publications demonstrate innovations in biohybrid devices, standardized biomaterial testing, and novel tissue patterning techniques. Her work integrates engineering, materials science, and clinical translation through collaborations with medtech spin-offs. Leadership and Recognition: Fellow of the European Alliance for Medical and Biological Engineering President-elect of the Heart Valve Society Member of AcademiaNet for Outstanding Female Scientists Recipient of NWO VICI grant and Aspasia award She leads multinational consortia in regenerative medicine and teaches courses on heart/blood physiology and regeneration. Her lab develops model systems spanning cellular to tissue levels to quantify mechanobiological processes.
Carlijn Vermeer is a PhD candidate in Medical Sciences at Utrecht University. She is affiliated with multiple strategic research programs, including Brain Developmental disorders, Neuro-oncology, Personalized psychiatry, Cancer Molecular science, Regenerative Medicine & Stem Cells, and Immune and cellular therapies. Current affiliations: Brain, Cancer, Child Health, Circulatory Health, Infection & Immunity, Regenerative Medicine & Stem Cells Key research areas: Epilepsy, Neuromuscular disorders, Stroke, Pediatrics and oncology, Inflammatory disorders, Biofabrication Her work spans diverse medical disciplines with a focus on translational research and advanced therapies.
Michael Levin is a Distinguished Professor at Tufts University in the Department of Biology within the School of Arts and Sciences. He serves as Director of both the Allen Discovery Center at Tufts University and the Tufts Center for Regenerative and Developmental Biology. His laboratory investigates the intersection of developmental biology, artificial life, bioengineering, synthetic morphology, and cognitive science. Allen Discovery Center at Tufts Tufts Center for Regenerative and Developmental Biology Tufts/UVM: ICDO Harvard Wyss Institute Stibel Dennett Consortium for Brain and Cognitive Science The Proteus Institute MIT Science and Technology Center EBICS Levin's research focuses on understanding diverse intelligence in evolved, designed, and hybrid complex systems. His lab combines developmental biophysics, computer science, and behavioral science to study how cognition scales up from cellular competencies to organism-level behaviors. A key specialty is developmental bioelectricity—the study of how somatic electrical networks store, process, and act on information to control large-scale body structure. His team creates tools to read and edit the bioelectric code guiding proto-cognitive computations in the body. Levin's publications reveal a strong focus on bioelectricity, morphogenesis, and non-neural cognition across multiple model systems including Xenopus, planarians, and synthetic living constructs. His recent work explores collective intelligence as a unifying concept across biological scales, the development of microfluidic devices for measuring electrical connectivity, and optical estimation of bioelectric patterns in living embryos. His research spans fundamental developmental mechanisms to potential biomedical applications in regeneration and disease treatment. As an editor, Levin serves as Co-Editor-in-Chief of Bioelectricity and Founding Associate Editor of Collective Intelligence. He has mentored numerous post-doctoral fellows and graduate students who have gone on to establish their own research programs. His lab has received significant attention for creating novel biological machines (xenobots) and demonstrating that cells can store and transmit behavioral memory outside the brain. The Levin Lab maintains several significant research initiatives including the Allen Discovery Center at Tufts, the Tufts Center for Regenerative and Developmental Biology, and collaborations with the Wyss Institute at Harvard. The lab employs a multidisciplinary approach combining wet lab experiments with computational modeling to investigate how living systems achieve goal-directed behavior and pattern formation.
Prof. dr. Sander van den Heuvel is a Professor in the Department of Biology at Utrecht University , specializing in developmental biology. He leads research on cell division control, particularly focusing on asymmetric division mechanisms and their coordination with differentiation in Caenorhabditis elegans . His work bridges fundamental developmental questions with applications in cancer biology and regenerative medicine. Research Interests Asymmetric cell division Developmental control of cell proliferation Spindle positioning in mitosis Wnt signaling in stem cells Epithelial tissue dynamics C. elegans as a model organism Publications & Activities : His recent work (2010–2014) explores spindle positioning, Argonaute-regulated cell shape, and G1/S inhibitors’ role in cell cycle arrest. These studies are connected to C. elegans , cancer biology, and developmental genetics. Scientific Awards NIH RO1 grants (1999, 2001) NIH PO1 grant (2002) AstraZeneca Academic Sponsorship (2003) Basil O’Connor Award (March of Dimes, 1999) Helen Hay Whitney Fellowship (1992) Grants : Received competitive NIH funding for studies on asymmetric division and cancer-related gene discovery. His lab also collaborates with institutions like the Netherlands Cancer Institute and Max Planck Institute.
Linda Kock is an Assistant Professor (Part-time) in the Department of Biomedical Engineering at Eindhoven University of Technology, specializing in the Orthopaedic Biomechanics research group. Her work focuses on developing ex vivo models for studying bone dynamics, liver function, and tissue engineering applications. Dr. Kock's research primarily centers on biomechanics and tissue engineering, with particular emphasis on: Ex vivo culture systems for bone and cartilage tissue Liver perfusion and transplantation models Organoid development and application in regenerative medicine Longitudinal monitoring of tissue dynamics using advanced imaging techniques Development of alternatives to animal experimentation in medical research Her recent publications demonstrate a strong focus on creating clinically relevant ex vivo models that bridge the gap between laboratory research and clinical applications, particularly in orthopaedics and liver transplantation. She has developed innovative approaches for monitoring bone remodeling through micro-CT scanning and has investigated the use of slaughterhouse-obtained livers as alternatives to laboratory pigs for perfusion research. Dr. Kock has received research funding from several prestigious sources including the European Union's Horizon 2020 research program under Marie Sklodowska-Curie grant agreements and the Netherlands Organization for Scientific Research through the ERC Proof of Concept program and Gravitation Program. She is actively contributing to the advancement of regenerative medicine techniques that align with the 3Rs principle (Replacement, Reduction, Refinement) in medical research, providing valuable platforms for testing drug treatments and evaluating implant performance under controlled conditions that better reflect human physiology.
Jaco van de Pol is a Full Professor of Computer Science at Aarhus University, holding dual roles in the Digital Society Institute and Formal Methods and Tools. He earned his PhD from Utrecht University in 1996, specializing in Termination of Higher-order Rewrite Systems, and a Master's in Computer Science (Term Rewriting) in 1992. His research focuses on model checking, formal methods, algorithms, and automated verification, contributing to UN Sustainable Development Goals related to innovation and education. Education: PhD, Termination of Higher-order Rewrite Systems, Utrecht University (1996) Master's in Computer Science (Term Rewriting), Utrecht University (1992) Research Interests: His work spans model checking, formal verification, parallel algorithms, and their applications in software engineering and bioengineering. He emphasizes practical formal methods, such as SCC algorithms and timed automata analysis, to solve complex computational challenges. Awards: Best Paper Award SPIN 2017 (2017) Best Student Paper Award (2018) Advising & Grants: Supervised 12 students and contributed to collaborative projects in formal methods and computational biology. His research has been applied to areas like cartilage phenotype modeling and parallel algorithm design. Labs/Teams: Engages with interdisciplinary teams, including computational biology and distributed systems groups, to advance formal methods in practical contexts.
Prof. Amir A. Zadpoor holds dual roles as Antoni van Leeuwenhoek Professor at TU Delft (Department of Biomechanical Engineering) and Professor of Orthopedics at Leiden University Medical Center. He leads the Additive Manufacturing Lab and specializes in biomaterials, tissue biomechanics, and orthopedic implants. His research focuses on 3D/4D printing, meta-biomaterials, and biodegradable metals for clinical applications. Key research interests include: designing function-tailored implants, antimicrobial biofunctionalized materials, and mechanically adaptive meta-implants. He has pioneered projects like 'Metallic clay' and 'Mechanobiology in-silico,' with applications in orthopedics and regenerative medicine. Notable awards include ERC grants, Vidi/Veni awards, and the Jean Leray Award. His lab develops deployable implants, self-folding origami lattices, and smart meta-implants. Ancillary roles include editorial positions at Springer Nature and directorships at Sylvanity/Zagres. Teaching includes courses on biomaterials, regenerative medicine, and computational biomechanics. Research outputs span over 150 peer-reviewed articles. Current priorities include sustainable biomaterials, AI-driven design optimization, and translating additive manufacturing innovations into clinical practice.
Tom F.A. de Greef is a Full Professor at Eindhoven University of Technology's Biomedical Engineering department, leading pioneering research at the intersection of synthetic biology, molecular computing, and engineered living systems. He founded the Center of Living Technologies and serves as a Core Professor at the Institute for Complex Molecular Systems (ICMS). Key research areas: Biological Computing Devices, DNA-based Data Storage, Engineered Living Materials, Synthetic Cell Engineering, Digital Chemistry, and Protocell Communication. His work has resulted in over 100 publications in Nature , Nature Chemistry , and Nature Nanotechnology , supported by prestigious awards including ERC Consolidator, Starting, and PoC grants, as well as NWO's VICI, VIDI, and VENI grants. He received the Cram-Lehn-Pedersen Prize in 2017 and was named a Groundbreaking TU/e Researcher in 2022. Leadership roles: Founding member of Center of Living Technologies, Principal Investigator at TU/e, and Fellow of the Netherlands Academy of Engineering. He supervises a large research group with >15 PhD students and leads collaborations across international institutions, focusing on programmable molecular systems and sustainable technologies aligned with UN SDGs.
Marianna Tryfonidou is a Professor at Utrecht University's Faculty of Veterinary Medicine, Department of Clinical Sciences, where she leads the Surgery of Companion Animals division and the Regenerative Orthopedics research group. She holds the position of EBVS® European Specialist in Small Animal Surgery and delivered her inaugural lecture on July 11, 2019. Professor Tryfonidou's research focuses on developing innovative treatments for osteoarthritis and back pain caused by intervertebral disc degeneration. Her work follows the One Health-One Medicine principle, aiming to create therapies that benefit both canine and human patients. She employs spontaneous diseased canine models as preclinical platforms for translation toward human applications, recognizing that dogs suffer from similar degenerative processes as humans. Her research has identified two primary treatment approaches: innovative drug delivery systems using biomaterials for pain relief in early-stage degeneration, and advanced stem cell therapies for advanced disc degeneration. Her iPSpine consortium received 15 million euros from the European Union to develop stem cell-based treatments that could rejuvenate worn intervertebral discs. Schimmel-Viruly Award (2008) NWO subsidy of €183,000 (2007) Tryfonidou has led multiple significant research projects including BioAID (biomimetic artificial intervertebral disc), William Hunter Revisited (cartilage repair), and ArIADNE (anti-inflammatory drug delivery systems). Her Regenerative Orthopedics group operates within the Regenerative Medicine Center Utrecht (RMCU) at Utrecht Science Park and maintains a biobank containing mesenchymal stromal cells, joint cartilage, and disc tissue from both healthy and degenerated sources.
Vidya Chandrasekaran is a Researcher at the Vrije Universiteit Amsterdam, affiliated with the Faculty of Science and the Department of Chemistry and Pharmaceutical Sciences. She holds an integrated Master's degree in Industrial Biotechnology from SASTRA University, India (2015), and is completing a PhD focused on iPSC-derived renal proximal tubule models for nephrotoxicity testing. Her research emphasizes developing in vitro systems for toxicity assessment using induced pluripotent stem cells (iPSCs). Key research areas include: iPSC differentiation protocols for kidney cells Nephrotoxicity testing using organoid models Transcriptomic analysis of toxic responses Animal-free chemical safety assessment She contributed to the in3 project , a multidisciplinary initiative for animal-free toxicity testing, alongside Prof. Paul Jennings. Her work has been published in journals like Toxicology in Vitro and Scientific Reports . Current projects involve advancing chronic toxicity prediction models and cadmium exposure mechanisms in renal cells. Collaborations include Harvard Medical School and Brigham and Women’s Hospital, focusing on kidney toxicology and regenerative medicine.
Dr. Sohrab Khatab is a Researcher in the Department of Orthopedics and Sports Medicine at Erasmus MC, a leading medical center affiliated with Erasmus University Rotterdam. His work focuses on innovative treatments for joint disorders, particularly using stem cell therapies and regenerative medicine approaches. Dr. Khatab's research spans multiple disciplines including orthopedics, veterinary science, and regenerative medicine. His primary interests include stem cell research, arthritis treatment, intra-articular therapies, and osteoarthritis management. His work utilizes various animal models including equine, murine, and in vitro systems to develop novel treatments for joint inflammation and cartilage damage. Analysis of Dr. Khatab's publications reveals a consistent focus on regenerative approaches for joint disorders. His research demonstrates expertise in stem cell secretome applications, platelet-rich plasma therapies, and biomaterial encapsulation techniques. The work shows progression from basic in vitro studies to more complex animal models, indicating translational research aimed at clinical applications in orthopedics and sports medicine. Dr. Khatab has collaborated extensively with researchers at Erasmus MC, particularly with G. van Osch, N. Kops, K. Bos, and J. Verhaar. His work has generated significant academic interest with multiple publications accumulating substantial citations in the field of orthopedic regenerative medicine. Dr. Khatab's research is conducted within the Orthopedics and Sports Medicine department at Erasmus MC, which appears to have strong capabilities in regenerative medicine, stem cell research, and translational orthopedics. His work with both equine and murine models suggests access to comprehensive laboratory facilities for preclinical testing of novel orthopedic treatments.
Professor Alain de Bruin (born 1968) is a distinguished academic at Utrecht University, serving as Professor in the Department of Biomolecular Health Sciences within the Faculty of Veterinary Medicine. Since January 1, 2020, he has been Head of the Department of Biomolecular Health Sciences. His academic journey began with veterinary medicine studies at the University of Hannover in Germany, followed by a PhD from the University of Bern in Switzerland in 1999. After specializing in veterinary pathology and completing a postdoctoral position at Ohio State University, he was appointed professor of pathobiology at Utrecht University in 2005. In 2010, he founded the Netherlands Molecular Pathology Center (UU/UMCG) and became an honorary professor of molecular pathology at the University of Groningen in 2014. Professor de Bruin's research primarily focuses on cancer biology, liver pathology, tumor suppression mechanisms, and aging processes. His expertise includes in vivo modeling, cell cycle analysis, generating transgenic mouse models, pathological analysis of animal disease models, and single-cell transcriptomics. His work centers on proteins that regulate cell proliferation, particularly E2F transcription factors, which he has discovered play critical roles in inhibiting cancer cell growth. His research themes span Life Sciences, Regenerative Medicine, and the Utrecht Platform for Organoid Technology. Analysis of his recent publications reveals a consistent research trajectory centered on cell cycle regulation, particularly the atypical E2F transcription factors (E2F7 and E2F8), and their roles in cancer development, polyploidization, and liver disease. His work demonstrates how these factors influence tumor suppression, angiogenesis, and cellular responses to DNA damage. The publications span multiple disciplines including cancer biology, molecular oncology, hepatology, and regenerative medicine, with applications in both human and veterinary medicine. Professor de Bruin has held significant leadership positions, including chairing the research council (2017-2019) and coordinating the 'Regenerative Medicine, Stem Cells, and Cancer' research program (2013-2019). He serves on the editorial board of 'Frontiers in Cell and Developmental Biology' and participates in review committees for NWO-Rubicon/Veni, the research alliance UTwente/UU/UMCU, and the Comprehensive Cancer Center at Ohio State University. His laboratory work has made significant contributions to understanding how E2F transcription factors regulate cell proliferation, with implications for developing novel cancer therapy strategies. His research on polyploidization mechanisms has provided insights into liver regeneration and tumor development, while his work on senescence has implications for aging-related diseases.
Peter H.M. Bovendeerd is an Assistant Professor in the Department of Biomedical Engineering at Eindhoven University of Technology (TU/e), specializing in the Cardiovascular Biomechanics research group. He holds affiliations with the Eindhoven MedTech Innovation Center and EAISI Health. His work focuses on developing mathematical models to interpret clinical patient data, particularly in cardiac electromechanics, perioperative monitoring, and perinatal monitoring, collaborating with Catharina Hospital and Máxima Medical Center. Academically, Bovendeerd earned his MSc in Applied Physics (cum laude, 1985) and PhD (1990) from TU/e and Maastricht University, respectively. His research integrates fundamental physical/physiological principles to estimate pathologies from patient data through inverse modeling, aiding diagnosis and treatment planning. He teaches courses including Biomechanics, Cardiac Function, and Continuum Mechanics. Recent research emphasizes fetal blood circulation modeling, cardiac mechanics frameworks, and post-infarct ventricular function. His work contributes to UN Sustainable Development Goals through advancements in healthcare technology and innovation.
